Tech Company M&A Transactions

Visiogen Acquisition

Visiogen, operating out of Irvine, was acquired by Abbott Laboratories. The transaction price was $400 million.

Transaction Overview

Company Name
Announced On
9/3/2009
Transaction Type
M&A
Amount
$400,000,000
M&A Terms
Financial terms of the transaction were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
2 Goodyear B
Irvine, CA 92618
USA
Email Address
Overview
Visiogen, Inc. is focused on developing innovative products for cataract and refractive patients. Founded in Irvine, California, in 2001, Visiogen's first commercial application, Synchrony, a dual-optic intraocular lens and pre-loaded injector, is currently in clinical studies in the U.S. and recently received a CE Mark in Europe.
Profile
Visiogen LinkedIn Company Profile
Social Media
Visiogen Company Twitter Account
Company News
Visiogen News
Facebook
Visiogen on Facebook
YouTube
Visiogen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Reza Zadno
  Reza Zadno LinkedIn Profile  Reza Zadno Twitter Account  Reza Zadno News  Reza Zadno on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/3/2009: Glacier Bay venture capital transaction
Next: 9/3/2009: MashLogic venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary